Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Published in Respiratory Medicine and

Journal Scan / Research · June 22, 2020

Safety and Immunogenicity of a Candidate MERS-CoV Viral-Vectored Vaccine

The Lancet Infectious Diseases

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Morgan Soffler MD

The Lancet Infectious Diseases

Safety and Immunogenicity of a Candidate Middle East Respiratory Syndrome Coronavirus Viral-Vectored Vaccine: A Dose-Escalation, Open-Label, Non-Randomised, Uncontrolled, Phase 1 Trial

Lancet Infect Dis 2020 Apr 20;[EPub Ahead of Print], PM Folegatti, M Bittaye, A Flaxman, FR Lopez, D Bellamy, A Kupke, C Mair, R Makinson, J Sheridan, C Rohde, S Halwe, Y Jeong, YS Park, JO Kim, M Song, A Boyd, N Tran, D Silman, I Poulton, M Datoo, J Marshal, Y Themistocleous, A Lawrie, R Roberts, E Berrie, S Becker, T Lambe, A Hill, K Ewer, S Gilbert

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

COVID-19

Safety and Immunogenicity of a Candidate MERS-CoV Viral-Vectored Vaccine

Additional Info

Safety and Immunogenicity of a Candidate Middle East Respiratory Syndrome Coronavirus Viral-Vectored Vaccine: A Dose-Escalation, Open-Label, Non-Randomised, Uncontrolled, Phase 1 Trial

Further Reading

Challenges Associated With the Initiation and Management of ECMO Support

Robotic-Assisted In-Bed Mobilization for Patients With COVID-19 Ventilated in the ICU

Acute Cardiac Events in Older Adults Hospitalized With Respiratory Syncytial Virus

Functional Limitations and Exercise Intolerance in Patients With Post-COVID Condition

Comparison Between Tuberculin Skin Testing and Interferon-γ Release Assays in Predicting TB

Delirium and Incident Dementia Among Patients Admitted to Hospitals in New South Wales, Australia

Effect of Enteral vs Parenteral Phosphate Replacement on Biochemistry, Waste, and Environmental Impact and Healthcare Cost Among Patients With Critical Illness With Mild to Moderate Hypophosphatemia

Efficacy of Nirmatrelvir in the Treatment of Vaccinated or Unvaccinated Adult Outpatients With COVID-19

Pathophysiology, Clinical Impact, and Management of Atrial Arrhythmias Among Patients With Pulmonary Hypertension

Association Between Emergency-Authorized Nonconventional Ventilator Use and Mortality Among Patients With COVID-19–Associated ARDS

Flow Cytometry as an Alternative to Microscopy for the Differentiation of Bronchoalveolar Lavage Fluid Leukocytes

Recently Updated